Pelvic disorders remain a common, yet stigmatized aspect of women’s health. Up to 50% of women over the age of 50 suffer from some form pelvic disorder such as incontinence or pelvic organ prolapse. Pelex is developing novel, non-invasive technology that is designed to treat the these conditions more effectively than any product currently available on the market. We are beginning pilot studies of our sensor platform and anticipate submitting for FDA clearance in Q4 2020.
Company’s Keywords:
medical device & patientcentric design
<4
<
<2019
Your request has been submitted successfully.
Own or work here?